Dr. Maisel, the founder of the Retina Group of New York, is a Board Certified ophthalmologist and Fellow of the American Academy of Ophthalmology who completed his Dyson fellowship in vitreous and retinal surgery at New York Presbyterian Hospital-Cornell Medical Center.

He served as a Corporate Advisory Board member for the Foundation of the American Academy of Ophthalmology (AAO) and the Juvenile Diabetes Foundation Medical Advisory Board. He was also a member of the AAO Instrument and Device and Low Vision Committees and has received research grants from the U.S. Public Health Service and the National Institute of Health.

Dr. Maisel represented the National Society to Prevent Blindness at the ANSI Z-80 committee where he helped establish many ophthalmic industry standards. He served as an editor of EyeCare Technology Magazine, authored numerous professional journal articles, and lectures nationally on retina, medical informatics and practice management topics. Dr. Maisel is also the chairman of ZyDoc Medical Transcription, a medical informatics company. In addition, he has been a clinical investigator, consultant, educator, and advisory board member for Pfizer, Novartis, EyeTech, TopCon, Genentech, Alimera, Regeneron and Allergan.

Dr. Maisel specializes in diabetic retinopathy, macular degeneration, retinal tears, retinal detachment, retinal vein occlusion, uveitis, cataract surgery complications, eye injuries, floaters, flashing lights, and offers second opinions.